Synthesis, Characterization, and Anticancer Activities Evaluation of Compounds Derived from 3,4-Dihydropyrimidin-2(1H)-one
Open Access
Abstract
3,4-dihydropyrimidin-2(1H)-one compounds (DHPMs) possess extensive biological activities and are mainly prepared via Biginelli reaction and N-alkylation. In the present study, selective alkylation of N1 was investigated by using tetrabutylammonium hydroxide. In vitro cytotoxicity study on all synthesized compounds demonstrated that introduction of the aryl chain in the R3 as well as the low electron-donating group in the R1 of DHPMs contributed to the anti-proliferative potency. A larger value of the partition coefficient (Log P) and suitable polar surface area (PSA) values were both found to be important in order to maintain the antitumor activity. The results from in vivo study indicated the great potential of compound 3d to serve as a lead compound for novel anti-tumor drugs to treat glioma. Pharmacophore study regarding the structure-activity relations of DHPMs were also conducted. Our results here could provide a guide for the design of novel bioactive 3,4-dihydropyrimidin-2(1H)-one compounds.Keywords
Funding Information
- National Natural Science Foundation of China (81502983)
This publication has 38 references indexed in Scilit:
- Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl groupBioorganic & Medicinal Chemistry Letters, 2012
- Structure–Activity Relationships and Molecular Docking of Novel Dihydropyrimidine‐Based Mitotic Eg5 InhibitorsChemMedChem, 2010
- Dihydropyrimidinone Positive Modulation of δ-Subunit-Containing γ-Aminobutyric Acid Type A Receptors, Including an Epilepsy-Linked Mutant VariantBiochemistry, 2010
- 2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assemblyBioorganic & Medicinal Chemistry Letters, 2010
- N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: Convenient one-pot selective synthesis and evaluation of their calcium channel blocking activityEuropean Journal of Medicinal Chemistry, 2009
- BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90Molecular Cancer Therapeutics, 2009
- Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancerNature Chemical Biology, 2007
- Dihydropyrimidin-(2H)-ones obtained by ultrasound irradiation: a new class of potential antioxidant agentsEuropean Journal of Medicinal Chemistry, 2006
- Selective N1‐Alkylation of 3,4‐Dihydropyrimidin‐2(1H)‐ones Using Mitsunobu‐Type Conditions.ChemInform, 2003
- T Cell Lymphoma in Transgenic Mice Expressing the HumanHsp70GeneBiochemical and Biophysical Research Communications, 1996